Page last updated: 2024-09-04

glucagon and Dementia

glucagon has been researched along with Dementia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freeman, J1
Marr, AP; Sanders, DJ; Zahedi-Asl, S1
Daimon, M; Ikezawa, Y; Kato, T; Kawanami, T; Maeda, K; Sasaki, H1
Bell, JD; Brooks, DJ; Chaudhuri, KR; Cunningham, VJ; Hammers, A; Hu, MT; Koepp, MJ; Labbé, C; Morris, RG; Taylor-Robinson, SD; Turjanski, N1

Reviews

1 review(s) available for glucagon and Dementia

ArticleYear
Management of hypoglycemia in older adults with type 2 diabetes.
    Postgraduate medicine, 2019, Volume: 131, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Continuity of Patient Care; Dementia; Diabetes Complications; Diabetes Mellitus, Type 2; Glucagon; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Patient-Centered Care; Practice Guidelines as Topic; Risk Factors; Time Factors

2019

Other Studies

3 other study(ies) available for glucagon and Dementia

ArticleYear
Glucagon and CCK in human brain: controls and patients with senile dementia of Alzheimer type.
    Progress in brain research, 1982, Volume: 55

    Topics: Alzheimer Disease; Brain; Brain Chemistry; Cholecystokinin; Dementia; Female; Glucagon; Humans; Male; Tissue Distribution

1982
Islet changes in hereditary ceruloplasmin deficiency.
    Human pathology, 1997, Volume: 28, Issue:4

    Topics: Ceruloplasmin; Copper; Dementia; Diabetes Mellitus; Glucagon; Humans; Immunohistochemistry; Insulin; Iron; Islets of Langerhans; Male; Middle Aged; Pancreas; Somatostatin

1997
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.
    Brain : a journal of neurology, 2000, Volume: 123 ( Pt 2)

    Topics: Aged; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucagon; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphorus Isotopes; Temporal Lobe; Tomography, Emission-Computed

2000